Clinical Trial Update: Probiotics Reduce Incidence of Necrotizing Enterocolitis for Very Low Birth Weight Infants [Phase 2]

View source ↗

Summary

Phase 2 trial investigating probiotics suggests a reduction in necrotizing enterocolitis among very low birth weight infants; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis

Drugs mentioned

• Probiotics

Snippet

Sponsor: China Medical University Hospital | Conditions: Enterocolitis, Necrotizing | Phase 2 | Status: TERMINATED